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Abstract In failing hearts cardiomyocytes undergo
alterations in cytoskeleton structure, contractility and
viability. It is not known presently, how stress-induced
changes of myofibrils correlate with markers for cell
death and contractile function in cardiomyocytes.
Therefore, we have studied the progression of con-
tractile dysfunction, myofibrillar damage and cell
death in cultured adult cardiomyocytes exposed to
the cancer therapy doxorubicin. We demonstrate, that
long-term cultured adult cardiomyocytes, a well-
established model for the study of myofibrillar struc-
ture and effects of growth factors, can also be used to
assess contractility and calcium handling. Adult rat
ventricular myocytes (ARVM) were isolated and
cultured for a total of 14 days in serum containing
medium. The organization of calcium-handling pro-
teins and myofibrillar structure in freshly isolated and
in long-term cultured adult cardiomyocytes was stud-
ied by immunofluorescence and electron microscopy.
Excitation contraction-coupling was analyzed by fura
2 and video edge detection in electrically paced
cardiomyocytes forming a monolayer, and cell death
and viability was measured by TUNEL assay, LDH
release, MTT assay, and Western blot for LC3. Adult
cardiomyocytes treated with Doxo showed apoptosis
and necrosis only at supraclinical concentrations.
Treated cells displayed merely alterations in cytoskel-
eton organization and integrity concomitant with
contractile dysfunction and up-regulation of auto-
phagosome formation, but no change in total sarco-
meric protein content. We propose, that myofibrillar
damage contributes to contractile dysfunction prior to
cell death in adult cardiomyocytes exposed to clini-
cally relevant concentrations of anthracyclines.
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Introduction
Contractile dysfunction in the failing heart is thought
to be due to irreversible cardiomyocyte loss, which
can be caused by cardiotoxic agents. A well-studied
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example of cardiotoxicity is cancer therapy with
anthracyclines, for instance with doxorubicin (Doxo),
which can be associated with early cardiomyopathy
as well as late-onset ventricular dysfunction (Lipsh-
ultz et al. 1991; Bristow et al. 1978). Possible
mechanisms of anthracycline-induced cardiotoxicity
are alterations in cellular structure (Lim et al. 2004),
induction of apoptosis (Sawyer et al. 1999), disrup-
tion of energy production (Tokarska-Schlattner et al.
2005) and formation of reactive oxygen species
(ROS) (Doroshow and Davies 1986). Anthracyclines
have been reported to induce structural changes and
cell death in the myocardium of treated patients, and
the extent of structural damage has been correlated
with early cardiac dysfunction (Billingham et al.
1978). However, it is not well known presently, how
anthracycline-induced morphological changes of car-
diac muscle cells correlate with markers for cell death
and contractile dysfunction.
The study of potentially cardiotoxic agents in
individual cardiac muscle cells is to some extent
limited by the currently available in vitro model
systems: cardiomyocytes from neonatal animals or
commercially available cell lines may respond differ-
ently to cytotoxic drugs compared to adult primary
cardiomyocytes due to differences in development-
specific gene expression, cell cycle activity and
apoptotic signaling (Konorev et al. 2008). Isolated
ventricular cardiomyocytes or muscle strips from
adult animals in serum-free conditions allow investi-
gations on electric properties, contractility and other
functions, but only for relatively short time. On the
other hand, adult rat ventricular cardiomyocytes
(ARVM) forming a monolayer of redifferentiated,
contracting cells in serum-containing media can be
maintained for several weeks and allow studies on
cytoskeleton remodeling, metabolic changes and long-
term effects of toxic agents and signaling modulators
(Lim et al. 2004; Pentassuglia et al. 2009; Eppenber-
ger-Eberhardt et al. 1997; Suzuki et al. 2001).
We have established a measurement procedure for
contractile activity and Ca2? transients in long-term
cultured ARVM in order to simultaneously evaluate
the progression of anthracycline-induced cardiotoxic-
ity and effects on EC-coupling. To correlate changes in
contractility and Ca2?-handling with cell death, we
have assessed a broad range of markers of cell viability
and damage such as mitochondrial enzyme activity,
plasma membrane integrity, DNA-degradation, a
marker of autophagosomes and selected sarcomeric
proteins. We also looked into the previously described
detrimental effect of Doxo on the myofibrillar appa-
ratus in cardiomyocytes, and its recovery potential
after washout of the drug in this model.
Materials and methods
Isolation and culture of adult rat ventricular
cardiomyocytes
Adult (250–300 g) male Wistar rats from an in-house
breeding facility were killed by pentobarbital (Nembu-
tal, Abbott Laboratories) injection. Isolation of calcium-
tolerant cardiomyocytes was achieved according to
previously published methods (Kondo et al. 1998). The
cardiomyocytes were plated onto laminin-coated glass
coverslips (10 lg/mL mouse laminin, Invitrogen) or
culture dishes (Nunc). Cardiomyocytes were cultured
for the long-term model in medium containing: 20%
fetal calf serum (FCS) (PAA laboratories), cytosine 1-b-
D-arabinofuranoside 10 lM, creatine monohydrate
(Sigma) 20 mM, penicillin 100 IU/mL and streptomy-
cin 100 lg/mL (Invitrogen) in MEM199 (Amimed).
For the serum-free culture model cardiomyocytes were
cultured in medium containing: fatty acid-free bovine
serum albumin 2 mg/mL, L-carnitine 2 mM, creatine
5 mM, taurine 5 mM, triiodothyronine 10 nM (all from
Sigma), penicillin 100 IU/mL and streptomycin
100 lg/mL (Invitrogen) in MEM199 (Amimed). All
experiments were carried out according to the Swiss
animal protection law and with the permission of the
state veterinary office of Bern. This investigation
conforms with the ‘‘Guide for the Care and Use of
Laboratory Animals’’ published by the US National
Institutes of Health (NIH Publication No. 85-23, revised
1996).
Immunofluorescence microscopy
Cultures were washed 3 times with PBS, fixed with 3%
para-formaldehyde for 15 min, permeabilized with
0.2% triton-X100 (Sigma) in PBS for 10 min, incu-
bated for 30 min with bovine serum albumin (Sigma)
1 mg/mL in PBS at room temperature, incubated over
night with primary antibodies at 4 C, washed 3 times
with PBS and incubated 1 h with the secondary
antibodies. Anti mouse monoclonal antibodies (mAb)
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for alpha-actinin (clone EA-53) and for desmin (clone
DE-U-10) were from Sigma, or from Abcam (SERCA
2ATPase, clone 2A7-A1; ryanodine receptor, clone
C3-33), and anti-myomesin (clone B-4) as a kind gift
from J.C. Perriard, ETH-Zurich, Switzerland. Anti-
mouse secondary antibodies were coupled with Alexa
Fluor-488 (Invitrogen) and phalloidin coupled to
Alexa Fluor-532 (Invitrogen) was used to visualize
actin filaments. The morphology of the cytoskeleton
was then analyzed using an inverted fluorescence
microscope LEITZ DM IL (Leica) equipped with a
409 oil objective (Olympus) and with a confocal
microscope (Zeiss LSM 410) using 409 and 649
objectives. Confocal images in Fig. 6 were taken using
a Leica TCS NT and an inverted microscope (Leica
DMIRB-E). Confocal microscopy images are shown as
single optical sections.
Electron microscopy
Cardiomyocytes cultured on laminin-coated glass
coverslips were fixed for 6 h at 4 C with 2%
glutaraldehyde (Fluka Chemika) in 0.1 M sodium
cacodylate buffer. Samples were then postfixed for
1 h in 1% osmium tetroxide, dehydrated stepwise to
70% ethanol and stained en bloc for 1 h in 2% uranyl
acetate in 70% ethanol. Dehydration was carried out
by incubation in 90–100% ethanol and several
mixtures of ethanol and propylenoxide (Sigma). After
dehydration was completed in 100% propylenoxide,
the cells were infiltrated within 24 h with an epoxy
resin based on Epon812 (Epon 20 g, DDSA 16 g,
NMA 7 g and DMP-30 1 g, all from Fluka Chemika)
in a series of ascending mixtures of epoxy resin/
propylenoxide. Gelatin capsules filled with 100%
resin were placed on the coverslips and the samples
were heat polymerized for 48 h at 60 C. Ultrathin
sections were cut on a Reichert Diatom ultramicro-
tome, placed on carbon and formvar coated copper
grids (Provac) and were poststained with uranyl
acetate and lead citrate according to standard proce-
dures. Preparations were examined in a JEOL
JEM100C transmission electron microscope at 80 kV.
Cell death assays
TUNEL (terminal deoxyribonucleotidyltransferase-
mediated d-uridine 50-triphosphate nick end labeling)
assay was performed according to the manufacturers
instructions (‘‘in situ cell death detection kit AP’’,
Roche Applied Science), with the exception of
prolonged permeabilization and incubation steps.
Incubation with DNAse-I (Sigma) was used as
positive control for DNA nick labeling. DNAse
incubation in fixed cardiomyocytes led to positive
nuclei in 100% of the cells (not shown). LDH release
test was performed according to the manufacturer
(‘‘cytotoxicity detection kit’’, Roche Applied Sci-
ence). Results were normalized assuming cultures
treated with 0.2% triton-X100 (Sigma) for 10 min as
100%. Absorption was measured using a Safire
microplate reader (Tecan). The reduction of MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) is thought to mainly occur in the mito-
chondria through the action of succinate dehydroge-
nase, therefore providing a measure of mitochondrial
function. After incubation in MTT for 2 h cells were
washed two times with PBS and lysed to release
formazan from active cardiomyocytes (lysis solution:
0.6% glacial acetic acid and 10% SDS in DMSO)
and lysates were analyzed in a Safire microplate
reader (Tecan).
Contractility and calcium transients
Isolated ARVM were cultured for 14 days in media
containing 20% FCS onto glass coverslips coated
with laminin. Coverslips were taken out of the culture
dishes after the indicated pharmacological treatment
and assembled in a closed field-stimulation chamber
including a temperature-controlled stage (Warner
Instruments Corp.) on an Olympus IX-50 inverted
microscope equipped with an UAPO-objective 209/
1.35 N.A. in Tyrode’s buffer containing 0.5 lM of
membrane-permeant fura-2-AM (Invitrogen) for
15 min and were rinsed with Tyrode’s buffer con-
taining probenecid 500 lM (Sigma) to prevent leak-
age of fura-2. Temperature stability of the chamber
assembly and superfused buffer was continuously
monitored and automatically maintained by a dual-
channel temperature controller (Warner Instruments
Corp.). The ‘‘SarcLen’’ sarcomere length recording
method was used to measure contractility by fast-
Fourier analysis of video images in real time with the
IonWizard program (IonOptix). The region of interest
was set to places where an unidirectional striation of
sarcomeres was discernible in the phase contrast
images. Field stimulation was performed using a
Cytotechnology (2009) 61:25–36 27
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MyoPacer (IonOptix) delivering 2-ms square-wave
bipolar pulses. Calcium and contraction transient
plots were obtained by averaging the measurements
of 10 (Fig. 3) or 27 (Fig. 5) cells for each condition.
The calcium-length loops in those figures were drawn
with the purpose to obtain a index of relative
myofibril Ca2? sensitivity based on the following
assumptions: Within each contraction, the phase-
plane diagram of sarcomere length and Ca2? forms a
counter-clockwise loop, as an analogy to the
pressure–volume relationship diagrams used to assess
contractile performance of the heart. During the
relaxation phase, the sarcomere length and Ca2?
transients (which slightly vary in magnitude during
each contraction) converge to a common trajectory.
This common trajectory occurs during the Ca2?
decline at a time point shortly after sarcomere re-
lengthening begins. Therefore, the trajectory of the
relaxing phase can be used as an index of relative
myofibril Ca2? sensitivity (Spurgeon et al. 1992).
Western blot analysis
Cardiomyocytes were cultured for 10 days in culture
dishes (Nunc) and treated as indicated in the
‘‘Results’’ section. Cells were quickly rinsed twice
with ice-cold phosphate buffered saline and lysed in
cold lysis buffer containing 3.7 M urea, 134.6 mM
Tris, 5.4% SDS, 2.3% NP-40, 4.45% beta-mercap-
toethanol, 4% glycerol, 6 mg/100 mL bromophenol
blue, and boiled for 5 min. After SDS-PAGE using
12% Novex gels (Invitrogen), proteins were wet-
transferred onto nitrocellulose membrane (BA85,
Whatman). Immunodetection was carried out after
blocking in 5% milk in TTBS (20 mM Tris base,
pH 7.5, 150 mM NaCl, 0.03% Tween-20) and
incubation with diluted specific antibodies. Poly-
clonal antibodies for LC3A/B were from Abcam
(ab58610), monoclonal antibodies for a-cardiac
actin (sarcomeric actin) (clone 5C5), for desmin
(clone DE-U-10), and for sarcomeric alpha-actinin
(clone EA-53) were from Sigma. Secondary anti-
bodies anti-mouse IgG/IgM or anti-rabbit IgG
coupled to horse radish peroxidase were from Pierce
(Thermo Scientific), as was the chemiluminescence
detection kit ‘‘SuperSignal Dura’’. Densitometry was
performed using a ChemiDoc documentation system
(BioRad).
Statistical analysis
All data are expressed as mean ± SEM. Statistical
analysis of differences between groups was per-
formed by Student’s unpaired t-tests or by one-way
ANOVA, followed by the Bonferroni post-test to
compare single treatments when appropriate using the
program Prism 5 (Graphpad).
Results
Structure and function of ARVM after isolation
and in long-term culture
In cell culture medium containing serum ARVM
undergo a process of de and redifferentiation, reestab-
lish cell–cell contacts, regenerate myofibrils and
resume spontaneous contractions (Eppenberger and
Zuppinger 1999; Eppenberger et al. 1988) (Fig. 1a–d).
The rather dramatic remodeling process from rod-
shaped cells in tissue to a monolayer in culture might
hinder regular EC-coupling because of a changed
spatial alignment of calcium-handling proteins and
Ca2? stores. We therefore compared the ultrastructure
of long-term cultured cells with freshly isolated
cardiomyocytes or tissue sections and investigated
the localization of Ca2?-handling proteins before
further exploring pharmacologic interventions
(Fig. 1). The ultrastructural features of the sarcoplas-
mic reticulum and myofibrils were present in the
polymorphic cultured cells, although at a lesser degree
of overall organization compared to adult rat ventric-
ular tissue. M-lines were occasionally discernible in
sarcomeres (Fig. 1c, d). While freshly isolated cells
presented a regular striated pattern of ryanodine-
receptor (RyR) and sarco-endoplasmic reticulum
ATPase (SERCA) proteins along the cell axis in
immunofluorescence microscopy (Fig. 1e, g), ARVM
cultured for 12 days showed a robust expression of the
same proteins, with regional differences in striation
presumably corresponding to myofibrils (Fig. 1f, h).
Adult cardiomyocytes usually started spontaneous
contractions around day 5 in culture.
We then tested the stability of paced contractions in
cultured cells with field pacing at increasing frequen-
cies in the range of 0.5–5 Hz (Fig. 2) and using
known modulators of cardiac EC-coupling (Fig. 3).
Despite the morphological differences between
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freshly isolated and cultured cardiomyocytes, long-
term cultured ARVM were observed to contract in a
regular and synchronous manner according to the
imposed frequency up to 5 Hz by electrical field
stimulation (Fig. 2). The beta adrenergic agonist
isoproterenol (ISO) (Sigma) at 100 nM, or the bona
fide myosin inhibitor 2,3-butanedione monoxime
(BDM) (Sigma) at 100 nM was used as positive or
negative modulator of contractility, respectively.
Although BDM in the millimolar range can inhibit
cardiac contractions completely, it was used in this
experiment at a low concentration in order to mod-
ulate EC-coupling only to some extent. Upon treat-
ment with BDM at 100 nM, the contractions were
Fig. 1 Fine structure and localization of calcium-handling
proteins in adult rat cardiomyocytes in the tissue, in freshly
isolated cells and in long-term culture. a, b ARVM were
cultured for a total of 14 days. a Time-lapse images of the
same area of the culture were collected by phase contrast
microscopy. b An example of a cardiomyocyte with well-
discernible sarcomeric striations in phase contrast light
microscopy at 14 days in culture. c, d Electron microscopy
of adult rat heart tissue (c) or of ARVM cultured for 14 days
(d) (scale bar 1 lm). Black arrows indicate triads or honey
comb-shaped sarcoplasmic reticulum in tissue and culture,
respectively. e–h ARVM cultured for 14 days (f and h) or
freshly dissociated cardiomyocytes (e and g) were fixed and
immunolabeled with mAb anti-RyR (e, f) or mAb anti-SERCA
(g, h) (all scale bars 10 lm)
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attenuated (Fig. 3a–c) in the monolayer of long-term
cultured cells, similarly as in freshly isolated ARVM
(data not shown). The calcium-length relationship
(Fig. 3c) demonstrated, that BDM-treated cardiomyo-
cytes required a rise in calcium before starting
contraction. Additionally, BDM decreased the steep-
ness of the relaxation trajectory in the calcium-length
diagram, indicating that the coupling between cyto-
plasmatic calcium and sarcomere shortening was
impaired. On the other hand, long-term cultured
cardiomyocytes exhibited increased systolic values
of cytoplasmic fura-2 ratios and faster kinetics after
ISO application (Fig. 3d–f). ISO treatment caused a
substantial increase in contractility, as it has been
Fig. 2 Test for the stability
of contractile activity in
long-term cultured
cardiomyocytes. ARVM
cultured for 14 days were
mounted in the
measurement chamber and
electrically stimulated at the
frequency of 0.5–5 Hz.
Sarcomeric contractions
were recorded as described
in the ‘‘Materials and
methods’’ section. The
X-axis is time (seconds) and
the Y-axis is the sarcomer
length (micrometer*100)
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demonstrated before in freshly isolated cardiomyo-
cytes (Spurgeon et al. 1992).
Effects of Doxo on the viability
of cardiomyocytes
Anthracyclines, which are widely used for cancer
chemotherapy, have been limited in clinical use
because of a dose–dependent cardiotoxicity. The
endpoint of Doxo-associated cardiotoxicity most
studied so far on the cellular level is cell death by
apoptosis or necrosis (Sawyer et al. 1999; Kumar
et al. 1999). We measured activity of mitochondrial
enzymes with the MTT-assay. A decrease of the
ability of the cells to convert the MTT substrate was
seen in the higher range of Doxo concentrations
(Fig. 1a). The LDH-assay was then used to measure
the release of LDH into the cell culture medium
indicating loss of plasma membrane integrity i.e.
necrosis. This assay showed a sharp increase in LDH-
release in the cultures at Doxo concentrations
[10 lM (Fig. 1b). We then measured the percentage
of TUNEL positive cells after treatment for 48 h
(Fig. 4c). While ARVM were clearly undergoing
apoptosis after treatment with Doxo at concentrations
[10 lM, no significant increase in TUNEL positive
cells was observed at the concentration of 1 and
10 lL. We then assessed several proteins by
Western blotting after treatment of ARVM for 48 h
(Fig. 1d). Microtubule-associated protein-1 light
chain 3 beta (LC3) is involved in autophagosome
formation and the amount of LC3-II is considered a
marker for number of autophagosomes in cells
(Gustafsson and Gottlieb 2009). Western blotting of
Doxo-treated ARVM with an antibody that recog-
nizes both LC3-I and LC3-II showed a gradual
increase of LC3-II with increasing concentrations of
Doxo. Detection of the myofibrillar proteins a-
cardiac actin, alpha-actinin, and the intermediate
filament protein desmin by Western blot showed
overall no overt differences in untreated compared to
Doxo-treated ARVM.
Fig. 3 Characterization of EC-coupling in redifferentiated
ARVM exposed to the uncoupling agent 2,3-butanedione 2-
monoxime (BDM) or to beta adrenergic stimulation by
isoproterenol (ISO). ARVM were cultured for 14 days and
exposed to BDM or ISO at 2 Hz field pacing. Kinetics of Fura-
2 ratios (a BDM, d ISO), of contraction (b BDM, e ISO), and
of the calcium-length relationship (c BDM, f ISO) are shown.
Line graphs were plotted from averaged results of 10 cells
from 2 hearts for each condition
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Impairment of EC-coupling by Doxo
Contractile defects were investigated in ARVM
cultured for 10 days and treated for 48 h with Doxo
at 10 lM (Fig. 5). Although systolic and diastolic
calcium increased by Doxo treatment, decreases of
calcium amplitude and prolongation of relaxation
kinetics, as had been seen before in serum-free
Fig. 4 Cell death and
viability of ARVM exposed
to different concentrations
of Doxo. Cardiomyocytes
were cultured for 12 days
and then incubated with
Doxo for 48 h. a MTT-
assay for mitochondrial
activity. b LDH release
assay indicating loss of cell
membrane integrity.
c TUNEL-assay for DNA
degradation. d
Representative Western
blots for the
autophagosomal protein
LC3I/II, and for the
sarcomeric proteins
a-cardiac actin, alpha-
actinin, and desmin.
*p \ 0.05 versus untreated,
**p \ 0.01 versus
untreated, ***p \ 0.001
versus untreated
Fig. 5 Doxo induces
contractile dysfunction and
myofibrillar
disorganization. a, b
ARVM treated with 1 lM
Doxo for 48 h (thin line) or
untreated (stronger line)
were measured for
contractility (a) and fura-2
ratios (b). c, d Calcium-
length diagrams
demonstrating the reduction
of the slope of contraction
and of relaxation, as well as
the myofibril sensitivity for
calcium in Doxo-treated (d)
cells compared to untreated
ones (c). Line graphs were
plotted from averaged
results of 27 cells from 3
hearts
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cultured cells treated with Doxo (Timolati et al.
2006), were not observed (Fig. 5a). The amplitude of
sarcomere shortening was reduced by Doxo (Fig. 5b).
In order to assess whether uncoupling of excitation–
contraction occurred, we used the calcium-length
diagram (Fig. 5c, d). The effect caused by Doxo was
similar to the one exerted by BDM (Fig. 3c),
indicating an inefficient coupling between calcium
cycling and sarcomere shortening.
Myofibrillar organization after wash-out of Doxo
Since cell death assays with different concentrations
of Doxo indicated, that irreversible cell death is not
observed in most ARVM at concentrations below
10 lM in our culture model, we tested the hypothesis,
that the myofibrillar organization of the cells would
improve after wash-out of Doxo (Fig. 6). To quantify
the effect of treatments on myofibril structure, an
investigator blinded to treatments counted the per-
centage of cells showing myofibrillar structural
damage or reduction of sarcomere area at the end
of a 15 days culture period after immunostaining for
myomesin and F-actin. An example of the myofibr-
illar organization of an untreated culture and after
10 lM Doxo for 48 h is shown in Fig. 6a, b. For the
wash-out experiment cardiomyocytes were cultured
for 7 days, then treated with Doxo for 18 h, followed
by a) two medium changes or b) a more intensive
wash-out protocol with daily changes and medium
Fig. 6 Myofibrillar
structural changes induced
by Doxo and recovery. a, b
ARVM cultured for 14 days
without treatment (a) or
after 48 h of 10 lM Doxo
(b) were fixed and
immunostained for actin
(red) and myomesin
(green). c For the recovery
experiments,
cardiomyocytes were
cultured for 7 days, then
treated with Doxo for 18 h,
followed by wash-out with
medium (black bars) or
medium supplemented with
N-acetylcystein (NAC) as
indicated (white bars). The
bar graph shows the results
of three independent
experiments with evaluation
of 200 cells for myofibrillar
changes in each condition.
Overall one-way ANOVA
p \ 0.0001 (Color figure
online)
Cytotechnology (2009) 61:25–36 33
123
including the antioxidant N-acetylcystein (NAC) as
indicated in the treatment scheme. This procedure
resulted in a trend to reduced myofibrillar damage
after the intensive wash-out protocol, which was most
pronounced at the concentration of 1 lM Doxo, but
not at higher concentrations of the drug.
Discussion
Many observations in patients as in animal and cell
culture models have repeatedly demonstrated the
cardiotoxic potential of anthracyclines. There is
controversy about to what extent apoptosis and other
forms of cell death contribute to cardiotoxicity
induced by anthracyclines in patients (Minotti et al.
2004; Gewirtz 1999). It was found in the present
study that Doxo affected cell viability and the
myofibrillar organization in adult cardiomyocytes,
the latter phenomenon occurring already at sub-
apoptotic (0–1 lM, see Figs. 4, 6) and clinically
more relevant concentrations of the cardiotoxic drug.
The total amounts of sarcomeric proteins such as a-
cardiac actin or the intermediate filament protein
desmin showed little changes after anthracycline
treatment when assayed by Western blotting. This
result showed, that the evident Doxo-induced damage
and loss of myofibrils as visualized by immunolabel-
ing and confocal microscopy was not accompanied
by a marked decrease in total protein of those
relatively long-lived sarcomeric components. Taken
together, we conclude that myofibrillar morphology,
but not apoptosis, can be considered a sensitive
marker for myocardial stress by anthracyclines. The
mechanism of this type of cellular injury is likely
multifactorial including the formation of reactive
oxygen species, elevation of cytoplasmic Ca2? con-
centration and activation of intracellular proteases as
well as inhibition of the mTOR signaling pathway
and the cardiac transcription factor GATA4 (Lim
et al. 2004; Pentassuglia et al. 2009; Timolati et al.
2006; Zhu et al. 2009). We have used myofibrillar
changes as a marker for cancer therapy-associated
cardiotoxicity with different classes of drugs such as
paclitaxel, anti-ErbB2 antibodies, MEK-inhibitors
and small tyrosine kinase inhibitors for ErbB1/ErbB2
(Pentassuglia et al. 2007, 2009; Sawyer et al. 2002).
We further investigated here, how the observed
changes after cardiotoxic drug treatment affect
contractility and calcium handling in the long-term
culture model, which is ideally suited to study drug
effects over a longer time period and to follow
cytoskeleton changes in detail. However, a major
concern regarding culture-induced changes of EC-
coupling has been the functionality of T-tubules,
which degenerate already 24–72 h after isolation in
cultured adult cardiomyocytes (Spurgeon et al. 1992).
These structures can be found again, although at a
lesser degree of organization and more reminiscent of
earlier developmental stages, in re-differentiated cells
cultured in serum-containing medium (Kostin et al.
1998; Poindexter et al. 2001). Despite differences in
the regulation of calcium cycling between freshly
isolated and cultured adult cardiomyocytes, mono-
layer cells are able to follow pacing by electrical field
stimulation as we have demonstrated here. Indeed,
long term cultured ARVM displayed a fairly
substantial sarcoplasmic network in vicinity of myo-
fibrils, when examined at the ultrastructural level of
resolution, and expressed Ca2?-handling proteins in a
sarcomeric distribution pattern. The cells exhibited a
frequency-dependent increase of contractility and
responded to beta-adrenergic stimulation. These
findings show, that long-term cultured ARVM dis-
play a contractile kinetic behavior qualitatively
similar to the freshly isolated cardiomyocytes. Thus,
we used this model to study how cytoskeleton
disorganization correlates with function in the model
of anthracycline-induced cardiotoxicity in vitro.
Similarly as BDM, Doxo shifted the relaxation
trajectory to the right, which can be considered a
crude index of the force developed by the cardio-
myocytes at the level of the cross bridge interaction.
Systolic calcium was increased by Doxo suggesting a
compensatory mechanism, which augments calcium
fluxes in order to overcome the decrease in efficiency
of the contractile apparatus. This phenomenon
occurred early and at concentrations of Doxo suffi-
cient to increase the amount of the autophagosome
marker LC3-II, but not to induce DNA degradation.
The removal of damaged organelles is assumed to
happen by macro-autophagy in mammalian cells
(Gustafsson and Gottlieb 2009). The here observed
increase of LC3-II in Doxo-treated cardiomyocytes
indicates the formation of an increased number of
autophagosomes already at lower doses of Doxo. At
present, there is no clear consensus in the literature to
which extent this pathway of organelle degradation
34 Cytotechnology (2009) 61:25–36
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contributes to cardiac survival or to even further
deterioration (Rothermel and Hill 2007). The absence
of cell death under these conditions supports the
notion that this type of contractile dysfunction is
potentially reversible, although we cannot exclude,
that the accumulation of degraded proteins and
damage to genetic material might lead to cell death
at a later time point.
We have assessed a possible reversibility of drug
effects on myofibrillar organization in a series of
experiments applying Doxo for a comparably short
time and washing out the drug for 7 days. There
seems to be only a limited capacity of the cells to
regenerate myofibrils after Doxo-induced injury.
However, the isolated cells in the in vitro model have
a limited lifespan and some properties of Doxo such as
DNA intercalation and aggregation in mitochondria
make it difficult to model in vitro the recovery of the
myocardium after anthracycline-induced injury.
We and others have observed strictly dose–
dependent effects of Doxo on cellular injury in
isolated adult cardiomyocytes with changes in gene
expression and enzyme activity at low concentra-
tions, but DNA degradation and loss of membrane
integrity only at very high concentrations. It is
therefore reasonable to conclude, that the multiple
mechanisms of action that have been ascribed to the
anthracyclines may be related to the utilization of
different drug concentrations under varied experi-
mental conditions. We propose that repeated and
perpetual exposure to potentially cardiotoxic drugs
forming reactive oxygen species leads to a sequential
progression of myofibril disorganization, uncoupling
of excitation–contraction and contractile failure in
individual cells. At a later stage, the cumulative
cardiac injury may reach an irreversible state leading
to loss of cardiomyocytes. Finally, the analysis of
contractile properties and myofibrillar organization of
long-term cultured adult cardiomyocytes may be a
useful tool to address clinically relevant mechanisms
of cardiotoxicity.
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